Some cancers characterized by dysregulated eIF4E include acute myeloid leukemia (AML), multiple myeloma, diffuse large B-cell lymphoma, breast cancer, prostate cancer, head and neck cancer, and others [132,142,145,154,155,156,157,159,160,161,162,163,164,165,166]. This evidence concerns the gene EIF4E and cancer.